等待開盤 07-17 09:30:00 美东时间
-0.060
-0.56%
OrthoPediatrics Corp. announced a significant milestone in its Global POISE Study, with over 600 implants being observed across 300+ pediatric patients. Launched in 2023, the multi-center, post-market study aims to assess the safety and efficacy of OrthoPediatrics' implant devices. Currently, 13 active sites in Canada, the U.S., Australia, New Zealand, and South Africa are participating. The study's insights will help refine devices for children ...
07-16 11:00
买入!Darden Restaurants获多家大行上调目标价;瑞银维持特斯拉"卖出"评级,目标价升至215美元>>
06-24 10:07
Orthofix ( ($OFIX) ) has shared an update. On June 18, 2025, Orthofix Medical I...
06-20 21:30
<p>Omega Flex, Inc. announced a regular quarterly dividend of $0.34 per share, payable on July 10, 2025, to shareholders of record on June 30, 2025. The Board of Directors will evaluate cash needs, operational results, financial condition, capital expenditures, potential acquisitions, and other relevant factors to determine future dividends each quarter. The press release includes forward-looking statements subject to uncertainties and risks, whi...
06-18 14:00
JMP Securities analyst David Turkaly reiterates Orthofix Medical (NASDAQ:OFIX) from Market Perform to Market Perform.
06-06 22:10
Orthofix ( ($OFIX) ) has issued an update. On April 1, 2025, Orthofix Medical I...
04-08 05:19
Orthofix Medical Inc (NASDAQ:OFIX) said on Wednesday it received U.S. FDA 510((k)) clearance and the European CE Mark for the TrueLok Elevate Transverse Bone Transport System. TrueLok Elevate offers ...
03-19 22:13
The latest announcement is out from Orthofix ( ($OFIX) ). On March 12, 2025, Or...
03-12 20:29
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1102154574572916737.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler:维持Prothena Corp(PRTA)"超配"评级,目标价从94美元升至110美元</p> <p>• Stifel:维持GH Research(GHRS)"买入"评级,目标价从18美元升至3
02-28 09:50
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1101791398596456448.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler:维持Prothena Corp(PRTA)"超配"评级,目标价从94美元升至110美元</p> <p>• HC Wainwright & Co.:维持Karyopharm Therape
02-27 11:06